Nightingale Health

Nightingale Health's disease risk detection becomes part of annual health assessments at Barnes Private Practice in London

Källa: MFN
Positiv

Sammanfattning

Nightingale Health har ingått ett avtal med Barnes Private Practice i London. Avtalet innebär att Nightingale Health Check, ett test för att bedöma risk för kroniska sjukdomar, kommer att erbjudas som en del av praktikens årliga hälsokontroller.

Analys

Detta avtal markerar en expansion för Nightingale Health inom den privata primärvården i Storbritannien. Barnes Private Practice, som är en del av HCA Healthcare UK, fokuserar på förebyggande vård, vilket stämmer väl överens med Nightingale Healths erbjudande. Tjänsten lanseras i november 2026.

Insikter

  • • Avtalet stärker Nightingale Healths närvaro på den brittiska marknaden.
  • • Fokus på förebyggande vård hos Barnes Private Practice skapar en god synergi.
  • • Tjänsten lanseras i november 2026, vilket indikerar en framtida intäktsström.
Fundamental påverkan
Positiv

Avtalet med Barnes Private Practice bidrar till ökad kommersialisering av Nightingale Healths hälsokontroller och stärker bolagets närvaro på den brittiska marknaden.

Omfattning: 3/10Liten påverkan
0 · Ingen påverkan10 · Avgörande påverkan

Poängen visar omfattning, inte förväntad kursrörelse.

Nightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF), a pioneer in disease risk detection and preventive health, and Barnes Private Practice, a private GP practice in south-west London, have entered into an agreement to provide the Nightingale Health Check as part of the practice's annual health assessments. The test assesses a person's risk of developing five common chronic diseases over the next 10 years from a single blood sample. The service launches at the practice in November 2026.

Nightingale Health Plc | Press Release | November 06, 2026 at 11:00:00 EET

Nightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF), a pioneer in disease risk detection and preventive health, and Barnes Private Practice, a private GP practice in south-west London, have entered into an agreement to provide the Nightingale Health Check as part of the practice's annual health assessments. The test assesses a person's risk of developing five common chronic diseases over the next 10 years from a single blood sample. The service launches at the practice in November 2026.

Under the agreement, Barnes Private Practice offers the test to its patients as part of their annual health assessment, and Nightingale Health analyses the blood samples. From a single blood sample, the Nightingale Health Check produces a 10-year risk estimate for five chronic diseases: heart attack, ischemic stroke, type 2 diabetes, chronic kidney disease, and fatty liver disease. The report also includes the person's Metabolic Age and Metabolic Resilience Score.

Barnes Private Practice is a family-friendly GP practice led by Dr Alain Palacci and Dr Alexandra Strachan, and part of HCA Healthcare UK. Preventive care, early intervention and long-term health are central to how the practice works. Its GPs are supported by consultants in cardiology, urology, dietetics, dermatology and physiotherapy, who regularly see patients at the practice.

"Prevention has always been at the heart of how we practise. The conditions we worry about most, from heart disease to type 2 diabetes, develop quietly for years before a patient feels anything. A routine blood test tells us how someone's values look today. The Nightingale Health Check tells us, from the same sample, how their risks are likely to develop over the next ten years, so we can plan with each patient, and with our visiting consultants where needed, what to do about them," say Dr Alain Palacci and Dr Alexandra Strachan, GPs at Barnes Private Practice.

"Many people already see their GP regularly to check on their health, and that is where disease risk should be detected. Barnes Private Practice has built its care around prevention and long-term health, and its GPs work closely with specialists when a patient needs more. With the Nightingale Health Check in the annual health assessment, patients learn their risks for the most common chronic diseases from one blood sample, and their own doctor can act on the results. This agreement continues our growth in private primary care in the United Kingdom," says Teemu Suna, CEO and Founder of Nightingale Health.

About Barnes Private Practice Barnes Private Practice is a private GP practice at 22 Castelnau, Barnes, London, led by Dr Alain Palacci and Dr Alexandra Strachan. The practice is part of HCA Healthcare UK. It offers GP consultations, health assessments, preventive medicine, women's health, travel medicine and weight management, with visiting consultants in cardiology, urology, dietetics, dermatology and physiotherapy. Patients who need further specialist care can be referred to HCA Healthcare UK's hospitals in central London.

Read more: https://www.hcahealthcare.co.uk/facilities/barnes-private-practice

For further information, please contactTeemu Suna, CEOir@nightingalehealth.com

About Nightingale HealthChronic diseases cause around 75% of deaths globally and place a growing burden on healthcare systems. The way to address this is preventive healthcare, but until recently the tools to detect disease risks at population scale have not existed. Nightingale Health has built them. The Nightingale Health Check is a blood-based risk detection test that identifies risks for multiple chronic diseases, including cardiovascular disease, type 2 diabetes, kidney disease, and fatty liver disease, from a single blood sample. It is designed to be applied population-wide, so healthcare systems can identify the people who would benefit most from preventive action before disease develops.

Nightingale Health's technology is validated in over 1,000 peer-reviewed scientific publications and is used in many of the world's leading health studies, including the UK Biobank. In Finland, the Nightingale Health Check is in nationwide healthcare use, and over 250,000 people have already received their results. Nightingale Health operates globally with a parent company in Finland and subsidiaries in countries such as Japan, the United States, Singapore, and the United Kingdom, and has customers in more than 34 countries across healthcare and medical research. The company's Series B shares are listed on the regulated market of Nasdaq Helsinki and on the OTCQX International market. Read more: https://nightingalehealth.com/